I-Pfizer COVID Vaccine = Ukuhlasela kwenhliziyo = Isizathu Sokwethuka?

I-Travel and Tourism iyimboni yomhlaba wonke enezigidigidi zamadola futhi ibuya ngamandla. I-COVID ikwazile ukumisa lo mkhakha. Umuthi wokugomela i-COVID ukwazile ukususa ukwesaba, futhi wavumela abantu ukuthi baphile ne-COVID futhi bahambe ne-COVID.

Ngaphandle komgomo, uPfizer uphume ne-Paxlovid, umuthi wokwelapha i-COVID.

Izindaba ezizungezayo mayelana nethuba lokufa ngenxa yesifo senhliziyo, ngoba umuntu uthola umgomo we-Pfizer kubangele ukukhathazeka ngisho nokwethuka okuthile emhlabeni. Kuyiqiniso noma kuyiqiniso kangakanani lokhu kukhathazeka?

E-Singapore, sebebonke abantu abangama-413 bathole izinkokhelo ezifika ku-$1,895,000 ezinkokhelweni ngaphansi kohlelo Losizo Lwezezimali Lokugomela I-Singapore (Vifap) kusukela ngomhlaka-31 Disemba, ngokusho kukaNgqongqoshe Wezempilo.

I-CDC e-United States igcizelela ukuthi imigomo isindisa izimpilo ngokuvikela izifo.

Izikhondlakhondla zenkundla yezokuxhumana ezihlanganisa i-Facebook, Twitter, kanye ne-YOUTUBE bezilokhu zenza izingxoxo ezingachemile ngale ndaba zingenzeki ngokuvimbela noma ubani ukuba athumele umbono “ongalungile” kumanethiwekhi abo. Lokhu kungenzeka ukuthi kudale amahlebezi ngemuva kokusabalala kwezinkulumo ezinkundleni zokuxhumana nokukhuluma ngomlomo.

Yize bungekho ubufakazi obubambekayo bokuthi umuthi wokugomela i-COVID-19 unyusa ubungozi bokuhlaselwa yinhliziyo, ungaholela ekuvuvukeni kwenhliziyo kwabanye abantu. Kodwa-ke, lo mphumela uba mnene futhi uyaphela nokwelashwa.

Ngokuvumelana ne Ezempilo, kubalulekile ukukhumbula ukuthi, ngokusho ucwaningo lwango-2021, izinga lokuvuvukala kwenhliziyo (i-myocarditis) eliphuma egomeni libonakala lenzeka ngenani eliphansi kakhulu kunokuvuvukala kwenhliziyo okubangelwa ukutheleleka nge-COVID-19.

Ngokwesiphetho sakamuva se Izikhungo Zokulawula Izifo zase-US, abantu abaningi abathola imithi yokugoma abanazo izinkinga ezinkulu. Imithi yokugoma, njenganoma yimiphi imithi, ingabangela imiphumela engemihle, kodwa eminingi ayivamile kakhulu futhi imnene kakhulu. Ezinye izinkinga zempilo ezilandela ukugoma azibangelwa imigomo. Ezimweni ezingavamile kakhulu, umgomo ungabangela inkinga enkulu

Uhlelo Lukazwelonke Lwesinxephezelo Sokulimala Kokugoma luyindlela engenaphutha ohlelweni lwezomthetho lwendabuko e-US lokuxazulula izicelo zokulimala komgomo - olufana nohlelo olunikezwa e-Singapore.

Yasungulwa ngeminyaka yawo-1980s ngemuva kokuthi amacala abhekene nezinkampani zokugoma nabahlinzeki bezempilo besabise ngokudala ukushoda kwemijovo futhi behlise amanani okugoma aseMelika, obekungadala ukuqubuka kabusha kwezifo ezigwemeka ngokugoma.

Ngemva kwesonto elilodwa i-FDA ne-CDC bathole ukukhathazeka kokuphepha okungenzeka okuxhumanisa ukushaywa kwe-ischemic kubantu abadala asebekhulile nomgomo obuyekeziwe we-Pfizer, i-Israel kanye nabalawuli bezidakamizwa be-EU bamemezele ukuthi abatholanga isixhumanisi phakathi kwalokhu kokubili.

I-ischemic stroke yenzeka lapho ukunikezwa kwegazi engxenyeni yobuchopho kuphazamiseka noma kuncishisiwe, okuvimbela izicubu zobuchopho ekutholeni umoya-mpilo nezakhi. Amangqamuzana obuchopho aqala ukufa emizuzwini embalwa. 

Lokhu kwananela kwa-Israyeli. "Asikaze sikuthole lokho, ngisho nangemva kokuba sesibuyile futhi sabheka yonke imininingwane yethu ngemuva kwesimemezelo se-FDA," kusho uSalman Zarka, inhloko yethimba lakwa-Israel, esitatimendeni esithunyelwe kwaReuters ngesonto eledlule.

NgoJan. 18, i-European Medicines Agency iphinde yatshela abeReuters ukuthi ayikakutholi ukukhathazeka ngokuphepha e-EU ngomgomo kodwa izoqhubeka nokuqapha imininingwane.

Kodwa-ke, i-FDA ne-CDC bakhiphe isitatimende sokuthi eyodwa kuphela yezinhlelo zayo eziningi zokuphepha, i-Vaccine Safety Datalink, ethole inkinga engaba khona:

Uphenyo olusheshayo lwesiginali ku-VSD luphakamise umbuzo wokuthi ngabe abantu abaneminyaka engama-65 nangaphezulu abathole Umgomo we-Pfizer-BioNTech COVID-19, i-Bivalent kungenzeka ukuthi babe nesifo sohlangothi lwe-ischemic ezinsukwini ezingama-21 ezilandela ukugonywa uma kuqhathaniswa nezinsuku ezingama-22. -44 kulandela ukugoma.

I-FDA ne-CDC ayitusi noma yiluphi “ushintsho endleleni yokugoma.”

U-69% wabantu base-US uqede uchungechunge lokuqala lokugoma, futhi u-16% - cishe abantu abayizigidi ezingu-50 - bathole ama-booster abuyekeziwe.